top of page

Dr. GPCR Newsletter September, 2021

Hello Readers,

This month is Summit week! Are you ready?

  • Dr. GPCR Summit 2021:  The program is complete! Don't miss a chance to listen to 25+ scientific talks.  Get your All-Access ticket before they're gone by visiting Eventbrite today!  Got your All-Access ticket already? Special shout out to our partners!  Check your inbox this week, you'll be able to invite a friend or colleague to join the Summit for Free!  Proceeds from the ticket sales will be used to provide the best 3 trainee talks with fantastic prizes including a personalized autographed copy of Dr. Lefkowitz's biography. Present a pre-recorded talk and get free access to the entire Summit! Hurry, the deadline to submit your talk is Friday, September 10th, 2021 at midnight EST. If you're facing financial difficulties or are a trainee who would like to attend but can't submit a pre-recorded talk reach out to us now! The live talks will be held on Zoom and everyone who registered will be able to ask their questions to the speakers all week on Microsoft Teams! You'll also be able to meet our partners on Teams. Make sure you have a profile picture set for both Zoom and Microsoft Teams!  We want to thank our partner Domain Therapeutics for their support and for helping us bring you to this fantastic summit. Domain Therapeutics is a biopharmaceutical company committed to discovering and developing innovative treatments for immuno-oncology tackling GPCR mediated immunosuppression. We are excited to announce that we are partnering with Twist Biopharma, a division of Twist Bioscience, for the 2nd edition of the Dr. GPCR Summit. Twist Biopharma provides end-to-end Solutions in Biologics Discovery & Early Development/ GPCR Therapeutics is also joining us as a partner of this year's Summit. GPCR Therapeutics's mission is to discover and develop innovative therapeutics targeting cancer based on the novel science of GPCR heteromers. We are happy to count Montana Molecular as our Summit partner for the second year in a row. Montana Molecular works with GPCR scientists to provide next-generation tools for analyzing GPCR signaling kinetics. Based in Bozeman Montana, the company develops genetically encoded, fluorescent biosensors that monitor signaling processes in living cells. Last but not least, thank you to SYnAbs for partnering with us to bring you to the Dr. GPCR Summit. SynAbs's vision is to fill the gap in the marketplace for innovative monoclonal antibodies against poor immunogenic compounds and complex antigens including GPCRs. SynAbs offers a custom monoclonal antibody generation service as a one-stop solution, from antigen design to multi-gram manufacturing of the monoclonal of interest.

  • Dr. GPCR Podcast: We did it! Episode 50 is now available. Our guest is my mentor Dr. Thomas P. Sakmar. A special thank you to the Sakmar Lab for sponsoring this episode of the podcast. We'll be bringing you new episodes in October 2021


1. Interesting papers published in August 2021

1.1 Receptor activation and signaling

1.2 Structural and molecular insights into GPCR function

1.3 GPCRs in Oncology and Immunology

1.4 GPCRs in Cardiology and Endocrinology

1.5 GPCRs in Neuroscience

1.6 Methods in GPCR Research

1.7 Review

2. Industry news

3. Meetings and webinars

4. Resources & Publication Opportunity